2021
DOI: 10.3389/fcvm.2021.781125
|View full text |Cite
|
Sign up to set email alerts
|

Not Baseline Atrial Fibrillation but New-Onset Atrial Fibrillation and the Loss of Left Atrial Function Are Essential for Predicting Poor Outcomes in Non-ischemic Cardiomyopathy

Abstract: Aims: The clinical impact of the type of atrial fibrillation (AF) has not been completely elucidated in non-ischemic cardiomyopathy (NICM). Although the structure and function of the left atrium (LA) provide prognostic information in patients with heart failure, the relationship of the AF type with LA structure and function in NICM is unclear.Methods: Consecutive patients with NICM who underwent cardiac magnetic resonance were evaluated and followed. Multivariable Cox regression models were used to estimate ha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 33 publications
0
1
0
Order By: Relevance
“…Between 4-15% of patients hospitalized with COVID-19 may develop NOAF [4][5][6], which not only portends worsened in-hospital prognosis [7] but is an independent predictor of major adverse cardiac events and death [8,9]. While there exists information about best practices for patients already on AC prior to hospitalization for COVID-19 [10], expert guidance regarding de novo AC strategy upon hospital discharge serves only to support a discussion of risks and benefits balanced with the risk of AF recurrence [1].…”
Section: Introductionmentioning
confidence: 99%
“…Between 4-15% of patients hospitalized with COVID-19 may develop NOAF [4][5][6], which not only portends worsened in-hospital prognosis [7] but is an independent predictor of major adverse cardiac events and death [8,9]. While there exists information about best practices for patients already on AC prior to hospitalization for COVID-19 [10], expert guidance regarding de novo AC strategy upon hospital discharge serves only to support a discussion of risks and benefits balanced with the risk of AF recurrence [1].…”
Section: Introductionmentioning
confidence: 99%